DPP-4 inhibitors on BlueMedicare Premier Rx (S5795-002)
Januvia, Tradjenta and the other "gliptins" for type 2 diabetes, checked against this plan's 2026 formulary (its list of covered drugs).
- Plan type
- Stand-alone drug plan (PDP), Arkansas
- Premium
- $181.20/month
- Deductible
- None
3 of 5 DPP-4 inhibitors are covered on this plan. None require prior authorization.
2 aren't on the formulary (saxagliptin and alogliptin).
- $23.45Tier 3
- from $24.55Tier 3
- $102.08Tier 3
Not on the formulary
saxagliptin, alogliptin
Patient cost for a 30-day supply at a preferred retail pharmacy. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.